News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Canakinumab improves survival in advanced NSCLC
07 Oct 2023
byStephen Padilla
Treatment with canakinumab appears beneficial to patients with advanced nonsmall cell lung cancer (NSCLC) with low T-cell infiltration (ie, low total count or immune desert phenotype), results of predefined exploratory biomarker analyses from the CANOPY-1 have shown.
07 Oct 2023

Liraglutide vs semaglutide: Which is a better GLP-1 RA for diabetic veterans?
06 Oct 2023
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) liraglutide and semaglutide are both effective at lowering haemoglobin A1c (A1c) among veterans with type 2 diabetes mellitus (T2DM), reports a recent study, which provides insights into key considerations for this population.
06 Oct 2023






